Corvus Pharmaceuticals
CRVS · NASDAQ
$10.23+$0.58 (+6.01%)TodayMarket closed ·
Prev close $9.65
Who owns CRVS
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 45.8% of CRVS’s shares.
- OrbiMed Advisors, LLC8.5%
- BlackRock Institutional Trust Company, N.A.7.1%
- State Street Investment Management (US)5.3%
- T. Rowe Price Associates, Inc.4.4%
- Next 6 largest institutions20.5%
- All other shareholders54.2%
| Holder | Shares | % of shares |
|---|---|---|
| OrbiMed Advisors, LLC | 7.17M | 8.52% |
| BlackRock Institutional Trust Company, N.A. | 5.95M | 7.08% |
| State Street Investment Management (US) | 4.47M | 5.32% |
| T. Rowe Price Associates, Inc. | 3.68M | 4.38% |
| Vanguard Capital Management, LLC | 3.29M | 3.92% |
| Adams Street Partners, LLC | 3.28M | 3.90% |
| Vivo Capital, LLC | 2.81M | 3.34% |
| Wellington Management Company, LLP | 2.73M | 3.25% |
| Perceptive Advisors LLC | 2.67M | 3.17% |
| Deep Track Capital LP | 2.49M | 2.96% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| State Street SPDR S&P Biotech ETF | 3.09M | 3.68% |
| Vanguard Total Stock Market Index Fund | 2.41M | 2.86% |
| iShares Russell 2000 ETF | 1.76M | 2.10% |
| T. Rowe Price New Horizons Fund | 963.96K | 1.15% |
| Vanguard Extended Market Index Fund | 853.51K | 1.01% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $333.69K (3 trades) of CRVS on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Moore David Scott | Award | 15.00K | — |
| Moore David Scott | Buy | 21.70K | $250.24K |
| van den Broek Richard | Award | 15.00K | — |
| Grais Linda | Award | 15.00K | — |
| Thompson Peter A. | Award | 15.00K | — |
| CLARK IAN T | Award | 15.00K | — |
| MILLER RICHARD A MD | Buy | 1.93K | $23.20K |
| MILLER RICHARD A MD | Buy | 5.00K | $60.25K |
| Chan Andrew C. | Award | 30.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 17.80M
- Days to cover
- 13.31
- % of shares outstanding
- 21.17%
- Average daily volume
- 1.34M
- Change since last report
- +3.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.